Cidara Therapeutics, Inc. Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc.

CDTX

Peringkat dalam Saham #3186
Cidara Therapeutics, Inc. is a biotechnology company specializing in the... Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
Harga Saham
$221.38
Terakhir disinkronkan: 2026-01-08
Kapitalisasi Pasar
$5.61B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
120.15%
Negara
US
Perdagangan Cidara Therapeutics, Inc. (CDTX)

Kategori

Healthcare
Riwayat pemecahan saham untuk Cidara Therapeutics, Inc. (CDTX)
Saham Cidara Therapeutics, Inc. (simbol: CDTX) telah mengalami total 1 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Apr 24, 2024.
Satu lembar saham CDTX yang dibeli sebelum Apr 24, 2024 sekarang setara dengan 0.05 lembar saham CDTX.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
2024-04-24 1:20 x0.05 x0.05
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL